Arakis

Contact
arakis.com
+441799532350

Arakis Ltd

Chesterford Research Park , Little Chesterford
CB10 1XL Saffron Walden
United Kingdom

Phone

arakis.com
Contact
Profile Products News
Contact

About Arakis

Arakis is an emerging specialty pharmaceutical company, with a therapeutic focus in inflammatory diseases, oncology adjunctive therapy and pain.

Read more about Arakis
Facts about Arakis
  • Focus : Manufacturer
  • Industry : Pharma

Product portfolio of Arakis

Product portfolio

Show all

News about Arakis

Arakis

02-Nov-2005 | research and development

Arakis completes Phase I trials of AD 337 in fibromyalgia syndrome

Sosei Co. Ltd announced that its wholly-owned subsidiary Arakis Ltd, has successfully completed Phase I single and multidose studies of AD 337, a novel ...

Read news
Arakis

19-Oct-2005 | business & finance

Arakis and Vectura announce start of phase IIb trial of NVA237 for COPD

Arakis Ltd. , a wholly-owned subsidiary of Sosei Co. Ltd. , and Vectura Group plc announced that their collaborative product, NVA237 (formerly AD 237), a ...

Read news
Arakis

07-Sep-2005 | research and development

Arakis commences Phase IIB trial for rheumatoid arthritis drug

Sosei Co. Ltd. announcee that its wholly-owned subsidiary Arakis Ltd ("Arakis"), has commenced a Phase IIb dose ranging study of AD 452, a novel, small ...

Read news
Show more news about Arakis

Here you will find Arakis Ltd

Last viewed contents

MedTech industry: Falling margins worldwide hit German companies hard - North American MedTechs maintain their profitability lead

MedTech industry: Falling margins worldwide hit German companies hard - North American MedTechs maintain their profitability lead

Go to page